Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (36)

2024

  1. Correction to: Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway (Nutrients, (2017), 9, 3, (288), 10.3390/nu9030288)

    Nutrients

  2. Prevalence of sarcopenic obesity according to different diagnostic methods and cut-off points in candidates for bariatric surgery

    Clinical Nutrition, Vol. 43, Núm. 5, pp. 1087-1093

  3. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

2023

  1. Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)

    Cancers

2021

  1. Disease-related malnutrition and sarcopenia predict worse outcome in medical inpatients: A cohort study

    Nutrients, Vol. 13, Núm. 9

2020

  1. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children

    Experimental and Molecular Medicine, Vol. 52, Núm. 7, pp. 1048-1061

2019

  1. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

  2. Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells

    Cancers, Vol. 11, Núm. 12

2018

  1. Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells

    Frontiers in Pharmacology, Vol. 9, Núm. MAY

  2. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors

    Experimental and Molecular Medicine, Vol. 50, Núm. 10

2017

  1. Effects of oral glutamine on inflammatory and autophagy responses in cancer patients treated with abdominal radiotherapy: A pilot randomized trial

    International Journal of Medical Sciences, Vol. 14, Núm. 11, pp. 1065-1071

  2. Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxiamediated mitophagy

    Oncotarget, Vol. 8, Núm. 53, pp. 91402-91414

  3. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma

    Journal of Pineal Research, Vol. 62, Núm. 1

  4. Protective effect of protocatechuic acid on TNBS-induced colitis in mice is associated with modulation of the SphK/S1P signaling pathway

    Nutrients, Vol. 9, Núm. 3

2016

  1. Modulation of autophagy by sorafenib: Effects on treatment response

    Frontiers in Pharmacology, Vol. 7, Núm. JUN

2015

  1. Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis

    PLoS ONE, Vol. 10, Núm. 12

2014

  1. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells

    Journal of Pineal Research, Vol. 56, Núm. 1, pp. 20-30

2013

  1. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

    British Journal of Cancer, Vol. 109, Núm. 1, pp. 83-91

2011

  1. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: Role of the MT1 receptor

    Journal of Pineal Research, Vol. 51, Núm. 4, pp. 463-471

2009

  1. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells

    Journal of Pineal Research, Vol. 47, Núm. 4, pp. 330-338